Dr. Fiona Morrissey:

Advocacy is key because it can help people to explore alternatives that they might not get to explore otherwise or which the clinicians might not have time to explore with them. Advocacy could support those patients to taper off their medications in consultation with their clinicians. We are looking for that kind of supported decision-making. We must remember that we have resources but they are all going into the area of medication and not into the alternatives and other supports. That does not cost a lot of money. The problem is that all of the resources at the moment are going into one area when we need to provide other supporting resources, such as independent advocacy and other supports, so that people can be supported to make decisions around medications. Such a system does not exist at the moment but it is critical.